IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding IO Biotech, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 14.3M | 13.9M | −363.7K (−2.5%) |
| Value | $32.8M | $26.1M | −$6.77M (−20.6%) |
New holders (2)
Institutions that held IO Biotech, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 1,400,000 | $2.63M | 0.01% |
| Citadel Advisors LLC | 46,842 | $87.6K | 0.00% |
Sold out (2)
Institutions that held IO Biotech, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 1,127,260 | $2.59M |
| Psagot Value Holdings Ltd. / (Israel) | 40,846 | $94.0K |